» Authors » Yoshinori Hasegawa

Yoshinori Hasegawa

Explore the profile of Yoshinori Hasegawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 420
Citations 5430
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Igarashi Y, Wada H, Muto M, Sone R, Hasegawa Y, Seino K
Inflamm Regen . 2025 Jan; 45(1):2. PMID: 39856797
Background: For the treatment of liver fibrosis, several novel cell therapies have been proposed. Autologous macrophage therapy has been reported as one of the promising treatments. So far, most studies...
2.
Miura I, Hasegawa Y, Ito M, Ezaz T, Ogata M
Biomolecules . 2025 Jan; 14(12. PMID: 39766273
is an ancestral homologous gene of the male-determining in eutherian mammals and determines maleness in medaka fish. In the Japanese frog, , is located on the Z and W chromosomes....
3.
Suzuki Y, Kawasaki T, Tatsumi K, Okaya T, Sato S, Shimada A, et al.
Int J Mol Sci . 2024 Dec; 25(23). PMID: 39684311
In hypoxic pulmonary hypertension (PH), pulmonary vascular remodeling is characterized by the emergence of activated adventitial fibroblasts, leading to medial smooth muscle hyperplasia. Previous studies have suggested that CD26/dipeptidyl peptidase-4...
4.
Sunata K, Miyata J, Kawashima Y, Konno R, Ishikawa M, Hasegawa Y, et al.
Front Immunol . 2024 Oct; 15:1445769. PMID: 39439801
Introduction: Elevated blood eosinophil levels in patients with chronic obstructive pulmonary disease (COPD) with or without asthma are linked to increased exacerbations and the effectiveness of inhaled corticosteroid treatment. This...
5.
Hayashi H, Ishii M, Hasegawa Y, Taniguchi M
Allergol Int . 2024 Oct; 74(1):51-65. PMID: 39419650
Characteristic symptoms of NSAID-exacerbated respiratory disease (N-ERD) include asthma, chronic eosinophilic rhinosinusitis with nasal polyposis, cysteinyl LT (CysLT) overproduction and NSAIDs hypersensitivity. Some N-ERD patients present with episodic treatment-resistant extra-respiratory...
6.
Kondoh Y, Furukawa T, Hozumi H, Suda T, Egashira R, Jokoh T, et al.
BMC Pulm Med . 2024 Oct; 24(1):511. PMID: 39396941
Background: Multidisciplinary discussion (MDD), in which physicians, radiologists, and pathologists communicate and diagnose together, has been reported to improve diagnostic accuracy compared to diagnoses made solely by physicians. However, even...
7.
Nakamura S, Wakahara K, Majima S, Yokoi E, Fukutani E, Otsuki R, et al.
BMC Pulm Med . 2024 Oct; 24(1):510. PMID: 39396940
Background: Although blood eosinophil count is recognized as a useful biomarker for the management of chronic obstructive pulmonary disease (COPD), the impact of eosinophils in COPD has not been fully...
8.
Yoshimoto N, Muramastsu K, Ito T, Zheng M, Izumi K, Natsuga K, et al.
J Invest Dermatol . 2024 Sep; PMID: 39326663
Bullous pemphigoid is an autoimmune subepidermal blistering disease caused by anti-type XVII collagen (COL17) antibodies. Bullous pemphigoid has some immunological features such as eosinophilic infiltration and the deposition of IgE...
9.
Sasaki H, Miyata J, Kawashima Y, Konno R, Ishikawa M, Hasegawa Y, et al.
Allergol Int . 2024 Sep; 74(1):156-165. PMID: 39307590
Background: Aspergillus fumigatus is a pathogenic fungus known to be associated with severe asthma and allergic bronchopulmonary mycosis. However, the precise mechanisms underlying airway inflammation remain unclear. In this study,...
10.
Lam D, Hasegawa Y, Fong K, Yoo C
Respirology . 2024 Sep; 29(11):940-941. PMID: 39278732
No abstract available.